Intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling and promotes fate decisions, stemness, and protection
Shannon M Kahan,Rakesh K Bakshi,Jennifer T Ingram,R Curtis Hendrickson,Elliot J Lefkowitz,David K Crossman,Laurie E Harrington,Casey T Weaver,Allan J Zajac,Shannon M. Kahan,Rakesh K. Bakshi,Jennifer T. Ingram,R. Curtis Hendrickson,Elliot J. Lefkowitz,David K. Crossman,Laurie E. Harrington,Casey T. Weaver,Allan J. Zajac
DOI: https://doi.org/10.1126/sciimmunol.abl6322
IF: 30.63
2022-02-11
Science Immunology
Abstract:Here, we show that the capacity to manufacture IL-2 identifies constituents of the expanded CD8 T cell effector pool that display stem-like features, preferentially survive, rapidly attain memory traits, resist exhaustion, and control chronic viral challenges. The cell-intrinsic synthesis of IL-2 by CD8 T cells attenuates the ability to receive IL-2–dependent STAT5 signals, thereby limiting terminal effector formation, endowing the IL-2–producing effector subset with superior protective powers. In contrast, the non–IL-2–producing effector cells respond to IL-2 signals and gain effector traits at the expense of memory formation. Despite having distinct properties during the effector phase, IL-2–producing and nonproducing CD8 T cells appear to converge transcriptionally as memory matures to form populations with equal recall abilities. Therefore, the potential to produce IL-2 during the effector, but not memory stage, is a consequential feature that dictates the protective capabilities of the response.
immunology